De-Iron: a phase 2 trial of the activity and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent myelodysplastic syndromes

Br J Haematol. 2020 Jun;189(6):e237-e240. doi: 10.1111/bjh.16669. Epub 2020 Apr 27.

¹ Royal Bournemouth and Christchurch NHS Foundation Trust, Bournemouth, UK.
² Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham, Birmingham, UK.
³ Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
⁴ Nottingham University Hospitals NHS Trust, Nottingham, UK.
⁵ Cardiovascular Magnetic Resonance (CMR) Unit, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
⁶ Research Department of Haematology, University College London, London, UK.
⁷ St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
⁸ Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK.

No abstract available

Publication types